Scientific article

Withaferin A induces cell death and differentiation in multiple myeloma cancer stem cells

Published inMedChemComm, vol. 8, no. 1, p. 112-121
Publication date2017

Multiple myeloma (MM) remains an incurable malignancy despite the development of novel therapeutics. This is believed to be due to a subset of rare chemotherapy-resistant cancer stem cells (CSCs). Differentiation therapy represents one strategy aimed at reducing the stemness of CSCs. The anticancer effect of withaferin A (WFA) was studied in MM-CSCs and RPMI 8226 MM tumoral plasma cells (RPMIs). WFA exhibited growth inhibitory effects in both MM-CSCs and RPMIs, with IC50 values of 649 and 224 nM, respectively. WFA also induced a G2 cell cycle arrest, as well as cell death and apoptosis. Although, WFA did not exhibit a direct anti-migratory effect, a remarkable morphological change was observed in MM-CSCs in response to WFA treatment. Using qPCR gene expression analyses, WFA caused a reduction in stemness markers, and a promotion of differentiation markers in MM-CSCs. These results warrant further investigation of WFA in relevant MM animal models.

Research group
Citation (ISO format)
ISSA, Mark Elia, CUENDET, Muriel. Withaferin A induces cell death and differentiation in multiple myeloma cancer stem cells. In: MedChemComm, 2017, vol. 8, n° 1, p. 112–121. doi: 10.1039/C6MD00410E
Main files (1)
Article (Published version)
ISSN of the journal2040-2503

Technical informations

Creation06/14/2017 10:06:00 AM
First validation06/14/2017 10:06:00 AM
Update time03/15/2023 1:47:22 AM
Status update03/15/2023 1:47:21 AM
Last indexation05/02/2024 7:23:04 PM
All rights reserved by Archive ouverte UNIGE and the University of GenevaunigeBlack